Biote Corp. BTMD Unsatisfied Pellet Procedures — Contract With Customer Liability Noncurrent
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Biote Corp. in its filing.
Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityNoncurrent.
The official record: Biote Corp.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Biote Corp.'s unsatisfied pellet procedures — contract with customer liability noncurrent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Biote Corp.'s unsatisfied pellet procedures — contract with customer liability noncurrent?
- Biote Corp. (BTMD) reported unsatisfied pellet procedures — contract with customer liability noncurrent of $315K in Q1 2026.
- How has Biote Corp.'s unsatisfied pellet procedures — contract with customer liability noncurrent changed year-over-year?
- Biote Corp.'s unsatisfied pellet procedures — contract with customer liability noncurrent decreased by 32.4% year-over-year, from $466K to $315K.
- What is the long-term trend for Biote Corp.'s unsatisfied pellet procedures — contract with customer liability noncurrent?
- Over 2 years (2023 to 2025), Biote Corp.'s unsatisfied pellet procedures — contract with customer liability noncurrent has grown at a 8.4% compound annual growth rate (CAGR), from $1.4M to $1.64M.
- What does unsatisfied pellet procedures — contract with customer liability noncurrent mean?
- This metric captures the long-term portion of deferred revenue related to hormone pellet procedures where the performance obligation is expected to be satisfied beyond the next fiscal year. It reflects the company's multi-year service commitments and the stability of its long-term practitioner relationships. A growing balance in this category may indicate strong long-term demand and sustained engagement within the hormone optimization practice-building ecosystem.